Chary Annageldiyev, MD

1.6K posts

Chary Annageldiyev, MD banner
Chary Annageldiyev, MD

Chary Annageldiyev, MD

@CharygulyMD

Hem/Onc fellow. ABIM Hem/Onc pathway. IM @pennsthershey | Retweets are not endorsements. My own opinions.

Hershey, PA, USA Katılım Aralık 2016
1.1K Takip Edilen850 Takipçiler
Chary Annageldiyev, MD retweetledi
Vincent Rajkumar
Vincent Rajkumar@VincentRK·
Unprecedented. #ASH25 Tec-Dara in relapsed myeloma. @mvmateos
Vincent Rajkumar tweet media
Slovenščina
13
117
350
131.9K
Chary Annageldiyev, MD retweetledi
Samer Al Hadidi, MD,MS,FACP
Samer Al Hadidi, MD,MS,FACP@HadidiSamer·
#ASH25 #mmsm @ASH_hematology Oral-myeloma Danish ABCD Study-prophylactic Tocilizumab RW data ➡️ prophylactic Tocilizumab decreased both G1 and G2 CRS (69% to 7.5%)👇 ➡️No difference in efficacy between both groups
Samer Al Hadidi, MD,MS,FACP tweet mediaSamer Al Hadidi, MD,MS,FACP tweet mediaSamer Al Hadidi, MD,MS,FACP tweet media
English
1
5
22
4.7K
Chary Annageldiyev, MD retweetledi
Benlazar S M A
Benlazar S M A@smbenlazar·
Treatment algorithm of plasmablastic lymphoma #lymsm #ASH25
Benlazar S M A tweet mediaBenlazar S M A tweet media
English
0
29
79
7.3K
Chary Annageldiyev, MD retweetledi
Benlazar S M A
Benlazar S M A@smbenlazar·
3 year of follow up confirms improved PFS with Nivo-AVD compared to BV-AVDin advanced stage Hodgkin lymphoma #ASH25
Benlazar S M A tweet mediaBenlazar S M A tweet mediaBenlazar S M A tweet mediaBenlazar S M A tweet media
English
0
17
48
2.4K
Chary Annageldiyev, MD
Chary Annageldiyev, MD@CharygulyMD·
Long-awaited study! Results of phase III trial comparing pona + blin vs imatinib + chemo. I wish pona was in both arms. Benefit of chemo-free regimen (TKI + blin) is now confirmed in a phase III study. @ASH_hematology #ASH25 #ASH2025
Chary Annageldiyev, MD tweet mediaChary Annageldiyev, MD tweet mediaChary Annageldiyev, MD tweet mediaChary Annageldiyev, MD tweet media
English
0
0
4
331
Scholarship for PhD
Scholarship for PhD@ScholarshipfPhd·
Say hi and I’ll recommend a research topic that perfectly fits your profile.
English
44.9K
2.6K
61.3K
6M

Keşfet

@NEJM @End_myeloma @mvmateos @ASH_hematology @DavidSteensma @VincentRK @einstein_aa @PennStHershey